While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

The U.S. Food and Drug Administration warns customers to not feed their pets certain lots of these pet food brands as they ...

Babies conceived through assisted reproductive technology are more likely to be born with a major heart defect, new research ...

People in the United States can order more free Covid-19 tests from the federal government this fall as the country heads ...

Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The US Food and Drug Administration has greenlit a new drug, marketed as Cobenfy, for oral use to treat schizophrenia in ...

Sanofi recorded 10.72 billion euros ($11.94 billion) in sales for Dupixent in 2023, which includes Regeneron's share.

The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

Lawmakers passed a law designed to limit reproductive rights in Louisiana. But it may also limit patients’ chances of ...

AbbVie on Friday said the application covers telisotuzumab vedotin, or teliso-V, in adults with previously treated, locally advanced or metastatic epidermal growth factor receptor wild type, ...

The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...